RETROSPECTIVE STUDY REGARDING THE EFFICACY OF 2ND OR HIGHER LINE CHEMOTHERAPY OF PATIENTS IN ADVANCED OR RECURRENT GASTRIC CANCER (ARGC) AFTER THE FAILURE OF S-1 OR S-1 COMBINATION CHEMOTHERAPY (S plus alpha)